Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1058310Generated: October 29, 2026

Triethylamine → 2-{2-{[tert-butyl(dimethylsilyl)oxy}-1-[(tert-butylsulfinyl)amino]ethyl}-5-chlorobenzyl)-1-[(9-hydroxy-9H-fluoren-9-yl)carbonyl]-L-prolinamide

https://huagongshe.com/reaction/1058310

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantHOAtHCID 181649—
Reactant9-hydroxy-9-fluorenylcarbonyl-L-prolineHCID 59038216—
ReactantN-(1-[2-(aminomethyl)-4-chlorophenyl]-2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)-2-methylpropane-2-sulfinamideHCID 69939402—
SolventDimethylformamideHCID 6228—
Product2-{2-{[tert-butyl(dimethylsilyl)oxy}-1-[(tert-butylsulfinyl)amino]ethyl}-5-chlorobenzyl)-1-[(9-hydroxy-9H-fluoren-9-yl)carbonyl]-L-prolinamideHCID 8658577461%

Reaction Steps

A mixture of diastereomer A of N-(1-[2-(aminomethyl)-4-chlorophenyl]-2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)-2-methylpropane-2-sulfinamide (from the previous step, 67 mg, 0.16 mmol, 1.07 eq), 1-[(9-hydroxy-9H-fluoren-9-yl)carbonyl]-L-proline (48 mg, 0.15 mmol, 1.0 eq (43 mg, 0.22 mmol, 1.5 eq), triethylamine (22 μL, 0.16 mmol, 1.07 eq) and HOAt (10 mg, 0.08 mmol, 0.5 eq) in anhydrous DMF (1 mL) was stirred at room temperature overnight. Most of the DMF was removed in vacuo and the residue was purified by silica gel chromatography (isocratic elution, 1:1 EtOAc:hexanes) to afford diastereomer A of N-(2-{2-{[tert-butyl(dimethylsilyl)oxy}-1-[(tert-butylsulfinyl)amino]ethyl}-5-chlorobenzyl)-1-[(9-hydroxy-9H-fluoren-9-yl)carbonyl]-L-prolinamide as a white solid (66 mg, 61%). 1H NMR (400 MHz, CDCl3): δ 7.66-7.64 (m, 2H), 7.44-7.00 (m, 9H), 5.91 (m, 1H), 4.71-4.58 (m, 3H), 4.40 (m, 1H), 4.35 (br s, 1H), 3.75 (dd, J=4.4, 10.3 Hz, 1H), 3.67 (apparent t, J=9.7 Hz, 1H), 2.38-2.28 (m, 2H), 2.02 (m, 1H), 1.81 (m, 1H), 1.65 (m, 1H), 1.45 (m, 1H), 1.23 (s, 9H), 0.91 (s, 9H), 0.08 (s, 3H), 0.00 (s, 3H). LCMS RT=3.05 min, (M+H)=724.6. Diastereomer B of the amine (17 mg from previous step) was coupled and purified under similar conditions to afford diastereomer B of N-(2-{2-{[tert-butyl(dimethylsilyl)oxy}-1-[(tert-butylsulfinyl)amino]ethyl}-5-chlorobenzyl)-1-[(9-hydroxy-9H-fluoren-9-yl)carbonyl]-L-prolinamide a a pale yellow oil (20 mg) which still contained traces of triphenylphosphine oxide from the previous step. LCMS RT=3.01 min, (M+H)=724.6.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06515011B2
Source datasetuspto-grants-2003_02
ORD IDord-47b147706a9b44c88fd47437681e4086
Source noteuspto-grants-2003_02